文献速递质量管理与危急值

危害严重程度评分数据库:实验室检测风险分析的循证基础

The severity of harm score database: an evidence-based foundation for laboratory test risk analysis.
PubMed 文献 · Clin Chem Lab Med · 2026-07-29

对19项共同检验项目合并分析(总n=781名受访者),确认心肌标志物、血气、凝血参数、电解质及治疗药物浓度获得最高严重程度评级。

要点

  • 数据库整合196项检验项目的危害严重程度序数分布与合并估计。
  • 19项共同项目合并分析(n=781)显示心肌标志物、血气、凝血、钾钠及地高辛/锂浓度严重程度最高。
  • 该资源支持CLSI EP23-ED2等标准要求的基于风险的质量管理策略。

核心结论

  • 危害严重程度证据数据库是首个公开的结构化实验室检验危害严重程度评估仓库,可支持风险管理合规与基于风险的策略制定。

研究设计与样本

  • 整合已发表独立研究中的调查评估,采用五级量表(可忽略、轻微、严重、危急、灾难性),覆盖196项检验项目。
  • 对19项两项研究共有的检验项目,按类别受访者计数直接合并,并计算Wilson得分置信区间。

主要发现

  • 196项检验项目中19项有合并估计,总受访者n=781。
  • 合并分析显示心肌标志物、血气、凝血参数、电解质(钾、钠)及治疗药物浓度(地高辛、锂)持续获得最高严重程度评级。
  • 某些内分泌标志物获得较低评分。

关键数值与推荐

  • 对19项共同检验项目进行直接计数合并,并计算所有比例的Wilson得分置信区间。

临床怎么用

  • 可用于满足CLSI EP23-ED2、ISO 15189:2022等标准中的风险管理要求。
  • 为实验室基于风险的策略提供循证基础,辅助确定检验项目风险优先级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient risk management has become central to clinical laboratory quality standards, including the Clinical and Laboratory Standards Institute (CLSI) EP23 2nd edition (CLSI EP23-ED2), International Organization for Standardization (ISO) 15189:2022, ISO 22367:2026, and ISO 14971:2019. A key component of risk analysis is estimating the severity of harm (SoH) that may result from erroneous laboratory results. We present here the Severity of Harm Evidence Database, a structured, multi-study resource that integrates survey-based SoH assessments from the published independent studies. The database provides ordinal distributions and pooled SoH for 196 unique laboratory tests. METHODS: A canonical five-level scale (negligible, minor, serious, critical, catastrophic) was adopted, aligned with ISO 14971:2019. For the 19 tests common to both studies, direct count pooling was performed by summing category-level respondent counts. Wilson score confidence intervals were calculated for all proportions. The database is organized into nine relational sheets and is accompanied by an interactive web application. RESULTS: Out of the 196 tests covered, 19 have pooled estimates from both studies (total n=781 respondents). Pooled analysis confirms that cardiac biomarkers, blood gases, coagulation parameters, electrolytes (potassium, sodium), and therapeutic drug concentrations (digoxin, lithium) consistently receive the highest severity ratings, while certain endocrine markers receive lower scores. CONCLUSIONS: The SoH evidence database offers the first publicly available, structured repository of SoH assessments for clinical laboratory tests. It supports compliance with risk management requirements, informs risk-based strategies per CLSI EP23-ED2, and provides an evidence-based foundation for laboratory risk analysis.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Çubukçu HC, Sonntag O, Lorde N, et al. The severity of harm score database: an evidence-based foundation for laboratory test risk analysis. Clin Chem Lab Med. 2026. PMID: 42517887. doi:10.1515/cclm-2026-0875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。